Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy

Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy

Chaudry Nasir Majeed,1 Christopher D Ma,2 Ted Xiao,3 Sean Rudnick,1 Herbert L Bonkovsky1 1Department of Internal Medicine, Section on Gastroenterology and Hepatology, Wake Forest School of Medicine, Winston-Salem, NC, USA; 2Wake Forest University School of Medicine, Winston-Salem, NC, USA; 3Departme...

Full description

Bibliographic Details
Main Authors: Majeed CN, Ma CD, Xiao T, Rudnick S, Bonkovsky HL
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:Drug Design, Development and Therapy
Subjects:
givosiran
small interfering rna’s. (sirnas)
5- (or δ)-aminolevulinic acid synthase 1 (alas1) expression inhibitors
porphyrias
Online Access:https://www.dovepress.com/spotlight-on-givosiran-as-a-treatment-option-for-adults-with-acute-hep-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/spotlight-on-givosiran-as-a-treatment-option-for-adults-with-acute-hep-peer-reviewed-fulltext-article-DDDT

Similar Items